Assorted news from the last two weeks: CAC2 Member blog post: “Diagnostic delays may be improved with targeted programs. The HeadSmart program, a web-based national
[vc_row][vc_column][vc_column_text] Assorted news from the last two weeks: Cures for many rare diseases might already exist. Why aren’t we using them? Patient advocacy groups have
Assorted news from the last week: Children conceived via assisted reproductive technology (ART) were not at increased risk of developing cancer later on, according to
Assorted news from the last week: U.S. News & World Report released this year’s rankings of the top pediatric cancer hospitals in the United States.
[vc_row][vc_column][vc_column_text] Assorted news from the last week: In a new study led by Yale Cancer Center researchers, neuromuscular dysfunction is found to be prevalent in
[vc_row][vc_column][vc_column_text] Assorted news from the last week: Late Effects Surveillance System-Study Scan is an online publication that follows survivorship issues. Click here for the latest
[vc_row][vc_column][vc_column_text] Assorted news from the last week: FDA issues its final guidance on the RACE Act and specifies when sponsors must conduct pediatric studies for
[vc_row][vc_column][vc_column_text] Assorted news from the last week: Thanks to a funding partnership among CAC2 Members, Spada Pediatric Sarcoma Foundation and Sam Day Foundation created theEwing
[vc_row][vc_column][vc_column_text] State-level advocacy is becoming a big opportunity across the country as it gives advocates another way to get involved in addition to going to
Assorted news from the last week: Survivors of childhood cancers are at increased risk for prescription opioid misuse compared with their peers, a review of
